Asset Details
Do you wish to reserve the book?
Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
Do you wish to request the book?
Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
2025
Overview
Background
Congenital hyperinsulinism is a rare disorder characterized by inappropriate insulin secretion, leading to persistent hypoglycemia. One genetic subtype, hyperinsulinism–hyperammonemia syndrome, results from activating mutations in the
GLUD1
gene. This study aimed to describe the clinical spectrum, genetic variants, and outcomes of patients with GLUD1-related hyperinsulinism–hyperammonemia syndrome treated at a tertiary care center in Saudi Arabia.
Methods
This retrospective case series included five patients of Saudi ethnicity diagnosed with
GLUD1
-associated hyperinsulinism–hyperammonemia syndrome between September and November 2023 at King Faisal Specialist Hospital and Research Centre. Clinical, biochemical, imaging, and genetic data were collected from medical records. Descriptive statistics were used to summarize the findings.
Results
All five patients (four pediatric, one adult) presented with hypoglycemia, elevated insulin levels, and persistent hyperammonemia. Genetic testing confirmed
GLUD1
mutations in all cases, with two patients sharing the c.1493C > T (p.Ser498Leu) variant. Diazoxide therapy effectively controlled hypoglycemia in most patients. Two patients experienced significant neurological complications, including seizures and developmental delay. One adult patient underwent pancreatectomy with improvement in hypoglycemia control but retained chronic neurological sequelae. Brain magnetic resonance imaging abnormalities and secondary genetic variants were identified in two cases.
Conclusion
GLUD1
-related hyperinsulinism–hyperammonemia syndrome presents with a wide clinical spectrum, often with early onset and risk of neurological impairment if not promptly treated. Early diagnosis and individualized management—including genetic testing and diazoxide therapy—are essential to prevent irreversible complications. Further multicenter studies are warranted to better understand long-term outcomes in affected populations.
